How should clinicians respond to high risk drinkers using no-lo products?

University of Sheffield et al argue that no/lo drinks could have an important role to play for people who drink at high-risk levels and those with alcohol use disorders or alcohol-related liver disease. “A zero-tolerance approach may alienate patients or erode trust in clinicians.” [Critics point to “stinking thinking” around alcohol-like substitutes.]